What are the major opportunities in the cancer immunotherapy market? What are the strategies for the cancer immunotherapy market?

For detailed insights on the major opportunities and strategies in the cancer immunotherapy market, Read More

How does the cancer immunotherapy market relate to the overall economy and other similar markets?

For detailed insights on cancer immunotherapy market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the cancer immunotherapy market growth? SWOT analysis of the cancer immunotherapy market.

For detailed insights on the key dynamics influencing the cancer immunotherapy market growth and SWOT analysis of the cancer immunotherapy industry, Read More

Cancer Immunotherapy Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Cancer Immunotherapy Market Report 2026

Name: Cancer Immunotherapy Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma), By End User (Hospitals, Cancer Research Centers, Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cancer Immunotherapy Market Overview

• Cancer Immunotherapy market size has reached to $124.09 billion in 2025

• Expected to grow to $210.39 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%

• Growth Driver: Driving Forces Cancer Incidence Surge And The Surge In Cancer Immunotherapy Demand

• Market Trend: Breakthrough PD-1 Therapy Expands Access For Advanced Lung Cancer Patients

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cancer Immunotherapy Market?

Cancer immunotherapy refers to a type of cancer therapy that strengthens your body's defenses against the disease. Your body's immune system aids in the defense against infections and other disorders. White blood cells, organs, and lymphatic system tissues make up this substance. Cancer immunotherapy comes in various forms, such as cytokines and vaccines, adoptive cell therapies, oncolytic viruses, tumor-infecting viruses, and others.

The main types of products of cancer immunotherapy are monoclonal antibodies, checkpoint inhibitors, immunomodulators, vaccines, and cell therapy. Monoclonal antibodies are man-made proteins that function in the immune system such as human antibodies. Cancer immunotherapy is used to treat lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, and multiple myeloma. These are used in hospitals, cancer research centers, and clinics.

Cancer Immunotherapy Market Global Report 2026 Market Report bar graph

What Is The Cancer Immunotherapy Market Size and Share 2026?

The cancer immunotherapy market size has grown rapidly in recent years. It will grow from $124.09 billion in 2025 to $137.99 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to breakthroughs in tumor immunology, rising global cancer incidence, early success of monoclonal antibodies, increased oncology R&D funding, regulatory approvals for checkpoint inhibitors.

What Is The Cancer Immunotherapy Market Growth Forecast?

The cancer immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $210.39 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to growing adoption of CAR T-cell therapies, expansion into solid tumor indications, increasing investment in cancer vaccines, rising demand for targeted combination therapies, supportive reimbursement policies for immunotherapy. Major trends in the forecast period include rapid adoption of immune checkpoint inhibitors, growing use of combination immunotherapy regimens, expansion of cell-based cancer therapies, rising focus on personalized immunotherapy, increasing number of oncology clinical trials.

Book your 30 minutes free consultation with our research experts

Global Cancer Immunotherapy Market Segmentation

1) By Product: Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy

2) By Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma

3) By End User: Hospitals, Cancer Research Centers, Clinics

Subsegments:

1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies

2) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

3) By Immunomodulators: Cytokines, Oncolytic Viruses, Toll-Like Receptor (TLR) Agonists

4) By Vaccines: Therapeutic Cancer Vaccines

5) By Cell Therapy: CAR T-Cell Therapy, TCR Therapy, Natural Killer (NK) Cell Therapy

What Is The Driver Of The Cancer Immunotherapy Market?

The rise in cancer incidence is expected to propel the cancer immunotherapy market. The factors contributing to the growth in cancer cases across the globe include tobacco, alcohol, obesity, a sedentary lifestyle, and environmental factors. This growth in cancer cases is expected to boost demand for cancer immunotherapies, as patients are increasingly investing in medical treatments with greater recovery and minimal pain. For instance, in July 2024, according to the projections published by Cancer Research UK, a UK-based cancer charity, cancer incidence rates in the United Kingdom are projected to increase for most types between 2023-2025 and 2038-2040, with rises ranging from less than 1% for breast cancer to 50% for eye cancer, while a smaller number of cancers are expected to see a decline, with reductions ranging from 2% for lung cancer to 27% for mesothelioma. Therefore, the increase in cancer incidence is expected to boost demand for cancer immunotherapy during forecast period.

Key Players In The Global Cancer Immunotherapy Market

Major companies operating in the cancer immunotherapy market are Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Bayer AG, Eli Lilly and Company, Adaptive Biotechnologies Corp., Argos Therapeutics Inc., Bristol-Myers Squibb Company, Cell Medica Limited, Cellular Biomedicine Group Inc., Gilead Sciences Inc., Gradalis Inc., Immatics Biotechnologies GmbH, Iovance Biotherapeutics Inc., Juno Therapeutics LLC, MacroGenics Inc., Merck & Co. Inc., Neon Therapeutics Inc., Neovii Biotech GmbH, Novartis International AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Roche Holding AG, Targovax ASA, Tessa Therapeutics Pte Ltd., TILT Biotherapeutics Ltd., Turnstone Biologics Corp., Xencor Inc., Kura Oncology Inc.

Global Cancer Immunotherapy Market Trends and Insights

Major companies operating in the cancer immunotherapy market are focusing on developing innovative solutions such as PD-1 immunotherapies to expand access to advanced immune-based treatment options for patients with hard-to-treat cancers. A PD-1 immunotherapy is an immune checkpoint–targeting treatment designed to stimulate antitumor immune activity by blocking programmed death-1 pathway interactions. For instance, in August 2025, Intas Pharmaceuticals, an India-based pharmaceutical company specializing in oncology and biologics, launched HETRONIFLY (Serplulimab). The therapy is the first programmed death-1 inhibitor approved globally for extensive-stage small cell lung cancer and utilizes a dual mechanism targeting PD-L1 and PD-L2 with strong receptor internalization to enhance immune engagement. Its demonstrated survival benefit and substantially reduced cost compared with existing immunotherapies underscore its clinical value and broaden patient access to advanced cancer treatment in India.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Cancer Immunotherapy Market?

In July 2024, Boehringer Ingelheim, a Germany-based pharmaceutical company, acquired Nerio Therapeutics for $1.3 billion. This acquisition will significantly enhance Boehringer Ingelheim's immuno-oncology portfolio by integrating Nerio's innovative preclinical program focused on immune checkpoint inhibitors. Nerio Therapeutics, a US-based biotech company, specializes in drug discovery and development, with a focus on phosphatases, a challenging yet highly promising class of therapeutic protein targets.

Regional Insights

North America was the largest region in the cancer immunotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cancer Immunotherapy Market?

The cancer immunotherapy market includes revenues earned by entities by helping the immune system fight cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cancer Immunotherapy Market Report 2026?

The cancer immunotherapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cancer immunotherapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Cancer Immunotherapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$137.99 billion
Revenue Forecast In 2035	$210.39 billion
Growth Rate	CAGR of 11.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Bayer AG, Eli Lilly and Company, Adaptive Biotechnologies Corp., Argos Therapeutics Inc., Bristol-Myers Squibb Company, Cell Medica Limited, Cellular Biomedicine Group Inc., Gilead Sciences Inc., Gra
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cancer Immunotherapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cancer Immunotherapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cancer Immunotherapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cancer Immunotherapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rapid Adoption Of Immune Checkpoint Inhibitors

4.2.2 Growing Use Of Combination Immunotherapy Regimens

4.2.3 Expansion Of Cell-Based Cancer Therapies

4.2.4 Rising Focus On Personalized Immunotherapy

4.2.5 Increasing Number Of Oncology Clinical Trials

5. Cancer Immunotherapy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cancer Research Centers

5.3 Specialty Oncology Clinics

5.4 Academic Medical Centers

5.5 Biopharmaceutical Research Institutes

6. Cancer Immunotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cancer Immunotherapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cancer Immunotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cancer Immunotherapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cancer Immunotherapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cancer Immunotherapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cancer Immunotherapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cancer Immunotherapy Market Segmentation

9.1. Global Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy

9.2. Global Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma

9.3. Global Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Cancer Research Centers, Clinics

9.4. Global Cancer Immunotherapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies

9.5. Global Cancer Immunotherapy Market, Sub-Segmentation Of Checkpoint Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

9.6. Global Cancer Immunotherapy Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cytokines, Oncolytic Viruses, Toll-Like Receptor (TLR) Agonists

9.7. Global Cancer Immunotherapy Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Therapeutic Cancer Vaccines

9.8. Global Cancer Immunotherapy Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

CAR T-Cell Therapy, TCR Therapy, Natural Killer (NK) Cell Therapy

10. Cancer Immunotherapy Market Regional And Country Analysis

10.1. Global Cancer Immunotherapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cancer Immunotherapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cancer Immunotherapy Market

11.1. Asia-Pacific Cancer Immunotherapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cancer Immunotherapy Market

12.1. China Cancer Immunotherapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cancer Immunotherapy Market

13.1. India Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cancer Immunotherapy Market

14.1. Japan Cancer Immunotherapy Market Overview

14.2. Japan Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cancer Immunotherapy Market

15.1. Australia Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cancer Immunotherapy Market

16.1. Indonesia Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cancer Immunotherapy Market

17.1. South Korea Cancer Immunotherapy Market Overview

17.2. South Korea Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cancer Immunotherapy Market

18.1. Taiwan Cancer Immunotherapy Market Overview

18.2. Taiwan Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cancer Immunotherapy Market

19.1. South East Asia Cancer Immunotherapy Market Overview

19.2. South East Asia Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cancer Immunotherapy Market

20.1. Western Europe Cancer Immunotherapy Market Overview

20.2. Western Europe Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cancer Immunotherapy Market

21.1. UK Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cancer Immunotherapy Market

22.1. Germany Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cancer Immunotherapy Market

23.1. France Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cancer Immunotherapy Market

24.1. Italy Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cancer Immunotherapy Market

25.1. Spain Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cancer Immunotherapy Market

26.1. Eastern Europe Cancer Immunotherapy Market Overview

26.2. Eastern Europe Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cancer Immunotherapy Market

27.1. Russia Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cancer Immunotherapy Market

28.1. North America Cancer Immunotherapy Market Overview

28.2. North America Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cancer Immunotherapy Market

29.1. USA Cancer Immunotherapy Market Overview

29.2. USA Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cancer Immunotherapy Market

30.1. Canada Cancer Immunotherapy Market Overview

30.2. Canada Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cancer Immunotherapy Market

31.1. South America Cancer Immunotherapy Market Overview

31.2. South America Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cancer Immunotherapy Market

32.1. Brazil Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cancer Immunotherapy Market

33.1. Middle East Cancer Immunotherapy Market Overview

33.2. Middle East Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cancer Immunotherapy Market

34.1. Africa Cancer Immunotherapy Market Overview

34.2. Africa Cancer Immunotherapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cancer Immunotherapy Market Regulatory and Investment Landscape

36. Cancer Immunotherapy Market Competitive Landscape And Company Profiles

36.1. Cancer Immunotherapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cancer Immunotherapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cancer Immunotherapy Market Company Profiles

36.3.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

37. Cancer Immunotherapy Market Other Major And Innovative Companies

Adaptive Biotechnologies Corp., Argos Therapeutics Inc., Bristol-Myers Squibb Company, Cell Medica Limited, Cellular Biomedicine Group Inc., Gilead Sciences Inc., Gradalis Inc., Immatics Biotechnologies GmbH, Iovance Biotherapeutics Inc., Juno Therapeutics LLC, MacroGenics Inc., Merck & Co. Inc., Neon Therapeutics Inc., Neovii Biotech GmbH, Novartis International AG

38. Global Cancer Immunotherapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cancer Immunotherapy Market

40. Cancer Immunotherapy Market High Potential Countries, Segments and Strategies

40.1 Cancer Immunotherapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Cancer Immunotherapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Cancer Immunotherapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Cancer Immunotherapy Market, Overview Of Key Products - Product Examples

Table 2: Global Cancer Immunotherapy Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Cancer Immunotherapy Market, Supply Chain Analysis

Table 4: Global Cancer Immunotherapy Market, Major Raw Material Providers

Table 5: Global Cancer Immunotherapy Market, Major Resource Providers

Table 6: Global Cancer Immunotherapy Market, Major Manufacturers (Suppliers)

Table 7: Global Cancer Immunotherapy Market, Major Distributors And Channel Partners

Table 8: Global Cancer Immunotherapy Market, Key Technologies & Future Trends

Table 9: Global Cancer Immunotherapy Market, Major Trends

Table 10: Global Cancer Immunotherapy Market, Major End Users

Table 11: Global Cancer Immunotherapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Cancer Immunotherapy Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Cancer Immunotherapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Cancer Immunotherapy Market - TAM, US$ Billion, 2025

Table 15: Global Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Cancer Immunotherapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Cancer Immunotherapy Market, Sub-Segmentation Of Checkpoint Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Cancer Immunotherapy Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Cancer Immunotherapy Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Cancer Immunotherapy Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Cancer Immunotherapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Cancer Immunotherapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Cancer Immunotherapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Cancer Immunotherapy Market - Company Scoring Matrix

Table 99: Amgen Inc. Financial Performance

Table 100: AstraZeneca PLC Financial Performance

Table 101: F. Hoffmann-La Roche Ltd Financial Performance

Table 102: Bayer AG Financial Performance

Table 103: Eli Lilly and Company Financial Performance

Table 104: Global Cancer Immunotherapy Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Cancer Immunotherapy Market, Competitive Dashboard

Table 106: Global Cancer Immunotherapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Cancer Immunotherapy Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 108: Global, Cancer Immunotherapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 109: Global, Cancer Immunotherapy Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Cancer Immunotherapy Market, Overview Of Key Products - Product Examples

Figure 2: Global Cancer Immunotherapy Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Cancer Immunotherapy Market, Supply Chain Analysis

Figure 4: Global Cancer Immunotherapy Market, Major Raw Material Providers

Figure 5: Global Cancer Immunotherapy Market, Major Resource Providers

Figure 6: Global Cancer Immunotherapy Market, Major Manufacturers (Suppliers)

Figure 7: Global Cancer Immunotherapy Market, Major Distributors And Channel Partners

Figure 8: Global Cancer Immunotherapy Market, Key Technologies & Future Trends

Figure 9: Global Cancer Immunotherapy Market, Major Trends

Figure 10: Global Cancer Immunotherapy Market, Major End Users

Figure 11: Global Cancer Immunotherapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Cancer Immunotherapy Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Cancer Immunotherapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Cancer Immunotherapy Market - TAM, US$ Billion, 2025

Figure 15: Global Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Cancer Immunotherapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Cancer Immunotherapy Market, Sub-Segmentation Of Checkpoint Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Cancer Immunotherapy Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Cancer Immunotherapy Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Cancer Immunotherapy Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Cancer Immunotherapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Cancer Immunotherapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Cancer Immunotherapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Cancer Immunotherapy Market - Company Scoring Matrix

Figure 99: Amgen Inc. Financial Performance

Figure 100: AstraZeneca PLC Financial Performance

Figure 101: F. Hoffmann-La Roche Ltd Financial Performance

Figure 102: Bayer AG Financial Performance

Figure 103: Eli Lilly and Company Financial Performance

Figure 104: Global Cancer Immunotherapy Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Cancer Immunotherapy Market, Competitive Dashboard

Figure 106: Global Cancer Immunotherapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Cancer Immunotherapy Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 108: Global, Cancer Immunotherapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 109: Global, Cancer Immunotherapy Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Cellular Immunotherapy Market Report 2026 - Global Outlook – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Kill...

Allergy Immunotherapy Market Report 2026 - Global Outlook – By Allergy Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, Allergic Conjunctivitis, Environmental Allergies), By Treatment (Subcutaneous ...

Tumor Infiltrating Lymphocytes Market Report 2026 - Global Outlook – By Anatomy (CD3, CD8, CD16, CD56, CD4, CD57, FOXP3), By Component (T-Cells, Natural Killer Cells), By Application (Melanoma, Cervical Cancer, Ovarian C...

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Immunohematology Market Report 2026 - Global Outlook – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PC...

Dendritic Cell Cancer Vaccine Market Report 2026 - Global Outlook – By Product (CreaVax, Sipuleucel-T (Provenge), Other Products), By Distribution Channel (Hospitals, Cancer Centers, Ambulatory Surgical Centers, Clinics)...

Immunodiagnostics Market Report 2026 - Global Outlook – By Product (Reagents And Consumables, Instruments), By Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid ...

Frequently Asked Questions

How big is the Cancer Immunotherapy Market?

The Cancer Immunotherapy market was valued at $124.09 billion in 2025, increased to $137.99 billion in 2026, and is projected to reach $210.39 billion by 2030. request a sample here

What is the Cancer Immunotherapy market growth?

The global Cancer Immunotherapy market is expected to grow at a CAGR of 11.1% from 2026 to 2035 to reach $210.39 billion by 2035. request a sample here

Who are the key players in Cancer Immunotherapy market?

Some Key Players in the Cancer Immunotherapy market Include, Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Bayer AG, Eli Lilly and Company, Adaptive Biotechnologies Corp., Argos Therapeutics Inc., Bristol-Myers Squibb Company, Cell Medica Limited, Cellular Biomedicine Group Inc., Gilead Sciences Inc., Gradalis Inc., Immatics Biotechnologies GmbH, Iovance Biotherapeutics Inc., Juno Therapeutics LLC, MacroGenics Inc., Merck & Co. Inc., Neon Therapeutics Inc., Neovii Biotech GmbH, Novartis International AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Roche Holding AG, Targovax ASA, Tessa Therapeutics Pte Ltd., TILT Biotherapeutics Ltd., Turnstone Biologics Corp., Xencor Inc., Kura Oncology Inc. . request a sample here

What is the anticipated growth trend for the Cancer Immunotherapy market?

Major trend in this market includes: Breakthrough PD-1 Therapy Expands Access For Advanced Lung Cancer Patients. For further insights on this market. request a sample here

Which region has the most growth potential in the Cancer Immunotherapy market?

North America was the largest region in the cancer immunotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Cancer Immunotherapy Market Report 2026 market?

Major companies operating in the Cancer Immunotherapy Market Report 2026 market are Major companies operating in the cancer immunotherapy market are Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Bayer AG, Eli Lilly and Company, Adaptive Biotec request a sample here.